Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS
Article in The Oncologist (February 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in The Oncologist (February 2024)
Article in Journal of the Formosan Medical Association (February 2023)
Article in Advances in Therapy (August 2022)